Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

The influence of feeding regimens on endogenous digoxin-like immunoreactive substance concentrations in infants.

Kurugöl Z, Ozyürek R, Levent E, Parlar A, Egemen A, Tuğlular I.

Acta Paediatr. 1996 Jun;85(6):753-4.

PMID:
8816218
2.

Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study.

Halken S, Hansen KS, Jacobsen HP, Estmann A, Faelling AE, Hansen LG, Kier SR, Lassen K, Lintrup M, Mortensen S, Ibsen KK, Osterballe O, Høst A.

Pediatr Allergy Immunol. 2000 Aug;11(3):149-61.

PMID:
10981524
3.

Infant feeding patterns affect the subsequent immunological features in cow's milk allergy.

Saarinen KM, Savilahti E.

Clin Exp Allergy. 2000 Mar;30(3):400-6.

PMID:
10691899
4.
5.

Digoxin-like immunoreactive substance in the elderly patient and its impact on the TDx digoxin assay.

Yamamoto T, Takano K, Sanaka M, Nomura Y, Koike Y, Mineshita S.

Ther Drug Monit. 1998 Aug;20(4):417-21.

PMID:
9712467
6.

Endogenous glycosides in critically ill patients.

Berendes E, Cullen P, Van Aken H, Zidek W, Erren M, Hübschen M, Weber T, Wirtz S, Tepel M, Walter M.

Crit Care Med. 2003 May;31(5):1331-7.

PMID:
12771599
7.

[Digoxin-like immunoreactivity in newborn infants--a pitfall of digoxin therapy?].

Heise HR, Vorwerk P, Fritsche K, Richter R.

Kinderarztl Prax. 1993 May;61(3):108-11. German.

PMID:
8326698
8.
9.
11.

Leptin levels in breast-fed and formula-fed infants.

Savino F, Costamagna M, Prino A, Oggero R, Silvestro L.

Acta Paediatr. 2002;91(9):897-902.

PMID:
12412862
12.
13.

Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes.

Vaarala O, Knip M, Paronen J, Hämäläinen AM, Muona P, Väätäinen M, Ilonen J, Simell O, Akerblom HK.

Diabetes. 1999 Jul;48(7):1389-94.

PMID:
10389843
15.

Role of digoxin-like immunoreactive substance in the pathogenesis of transient tachypnea of newborn.

Yalaz M, Levent E, Olukman M, Calkavur S, Akisu M, Kultursay N.

Biomed Res Int. 2013;2013:704763. doi: 10.1155/2013/704763. Epub 2013 Jul 7.

16.

Digoxin-like immunoreactive substance in postmortem blood of infants and children.

Spiehler VR, Fischer WR, Richards RG.

J Forensic Sci. 1985 Jan;30(1):86-91.

PMID:
3981124
17.

Bovine beta-casein antibodies in breast- and bottle-fed infants: their relevance in Type 1 diabetes.

Monetini L, Cavallo MG, Stefanini L, Ferrazzoli F, Bizzarri C, Marietti G, Curro V, Cervoni M, Pozzilli P; IMDIAB Group.

Diabetes Metab Res Rev. 2001 Jan-Feb;17(1):51-4.

PMID:
11241891
18.

Characterization of the carrier protein of digoxin-like immunoreactive substance in plasma.

Montali U, Balzan S, Ghione S.

J Hypertens Suppl. 1987 Dec;5(5):S299-302.

PMID:
3481818
19.

Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.

Mojaverian P, Green PJ, Jhangiania RK, Chase GD.

J Pharm Biomed Anal. 1989;7(5):585-92.

PMID:
2490762
20.

Short duration of breastfeeding and early introduction of cow's milk as a result of mothers' low level of education.

Ummarino M, Albano F, De Marco G, Mangani S, Aceto B, Ummarino D, Correra A, Giannetti E, De Vizia B, Guarino A.

Acta Paediatr Suppl. 2003 Sep;91(441):12-7.

PMID:
14599037

Supplemental Content

Support Center